http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2376564-B1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_431a1382d81de7fa6044ee3b03ec4020 |
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-73 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-395 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-286 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-395 |
| filingDate | 2010-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2013-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_519026b073ffb6e2c406d68c57dfe1cd |
| publicationDate | 2013-01-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2376564-B1 |
| titleOfInvention | USE OF ANTIBODIES AGAINST NK1, NK2 AND / OR NK3 RECEPTORS, TO PRODUCE APOPTOSIS IN TUMOR CELLS AND TO MODIFY STRAMA, IMMUNITY AND INTRA AND PERITUMORAL VASCULARIZATION, AS TREATMENT OF CANCER. |
| abstract | The object of the present invention is the use of an antibody or a specific fragment thereof against the NK1, NK2 and / or NK3 receptors of the cells, for the manufacture of a medicament for the therapeutic treatment of human cancer, by direct administration to A mammal, including man. In particular, in the case of melanoma, carcinomas (especially carcinoma of the breast, lung, digestive system, prostate, thyroid, uterine cervix, endometrium, ovarian and bladder urine), leukemia, lymphomas , glial excision neoplasms, neoplasms of neuroectodermal origin, Edwing's human sarcoma, other sarcomas (such as rhabdomyosarcoma and osteosarcoma) and other neoplasms such as neuroblastoma, medulloblastoma and nephroblastoma. |
| priorityDate | 2010-08-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 61.